Abstract:Alzheimer's disease (AD) involves multiple pathological factors that mutually cooperate and closely contact to form interaction networks for jointly promoting the AD progression. Therefore, the comonitoring of different factors is particularly valuable for elucidating their level dynamics and complex interactions. However, such significant investigations remain a major challenge due to the lack of unimolecular fluorescent probes capable of simultaneous and discriminative visualization of multiple targets. To address this concern, as proof of principle, we rationally designed a unimolecular fluorescent probe to discriminate and simultaneously profile amyloid-β (Aβ) plaques and peroxynitrite (ONOO-), which are both the pronounced AD pathological factors. Herein, a novel ONOO- reaction trigger was installed onto an Aβ plaque binding fluorophore to generate a dual functional fluorescent probe, displaying completely separate spectral responses to Aβ plaques and ONOO- with high selectivity and sensitivity. With this probe, for the first time, we comonitored the distribution and variation of Aβ plaques and ONOO- through two independent fluorescence channels, demonstrating their close apposition and tight correlation during AD course in live cell and mouse models through two-photon imaging mode. Notably, Aβ aggregates induce the neuronal ONOO- generation, which conversely facilitates Aβ aggregation. The two critical events, ONOO- stress and Aβ aggregation, mutually amplify each other through positive feedback mechanisms and jointly promote the AD onset and progression. Furthermore, by coimaging of the level dynamics of Aβ plaques and ONOO-, we found that the cerebral ONOO- is a potential biomarker, which emerges earlier than Aβ plaques in transgenic mouse models. Overall, the dual-channel responsive performance renders this probe as a powerful imaging tool to decipher Aβ plaque-ONOO- interactions, which will facilitate AD-associated molecular pathogenesis elucidation and multitarget drug discovery.

Research Progress Of Multi-Functional Fluorescent Probes For Alzheimer'S Disease Monitoring

Recent Research Progress in Fluorescent Probes for Detection of Amyloid- In Vivo

Application of Biomarker-Derived Fluorescent Probes for the Detection of Alzheimer's Disease

Shedding Light on Alzheimer's Disease: Recent Advances in Highly Selective Fluorescent Probes

Current strategies for the development of fluorescence-based molecular probes for visualizing the enzymes and proteins associated with Alzheimer’s disease

Advances in development of fluorescent probes for detecting amyloid-β aggregates

Potential of fluorescent nanoprobe in diagnosis and treatment of Alzheimer's disease

Light-controlled Fluorescent Probes for Precisely Monitoring Brain Amyloid-Β Aggregates in Alzheimer's Disease

Advances of Molecular Imaging Probes for the Diagnosis of Alzheimer's Disease.

Dual-functional AIE fluorescent probes for imaging -amyloid plaques and lipid droplets

Development of Near-Infrared Fluorescent Probes for Use in Alzheimers Disease Diagnosis

Development of Near-Infrared Fluorescent Probes for Use in Alzheimer’s Disease Diagnosis

Recent Advances in Fabricating the Multifunctional A beta Small Organic Molecule Probes for Theranostic Application

Molecular Imaging of Fluorinated Probes for Tau Protein and Amyloid-β Detection

Rational construction and evaluation of a dual-functional near-infrared fluorescent probe for the imaging of Amyloid-β and mitochondrial viscosity

GFP-based Red-Emissive Fluorescent Probes for Dual Imaging of Β-Amyloid Plaques and Mitochondrial Viscosity.

Targeting Β-Amyloid Plaques and Oligomers: Development of Near-Ir Fluorescence Imaging Probes.

Blood-based Alzheimer’s Disease Diagnosis Using Fluorescent Peptide Nanoparticle Arrays

Dual-Channel Imaging of Amyloid-β Plaques and Peroxynitrite to Illuminate Their Correlations in Alzheimer’s Disease Using a Unimolecular Two-Photon Fluorescent Probe

Curcumin Complex Analogues as Near-Infrared Fluorescent Probes for Monitoring all A beta Species in the Early Alzheimer's Disease Model

Fluorescent Peptide Nanoparticles to Monitor Aβ Oligomers